1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Safety, effectiveness, and quality of life following pulmonary vein isolation with a multi-electrode radiofrequency balloon catheter in paroxysmal atrial fibrillation: 1-year outcomes from SHINE

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          To evaluate the safety and effectiveness of a compliant multi-electrode radiofrequency balloon catheter (RFB) used with a multi-electrode diagnostic catheter for pulmonary vein isolation (PVI).

          Methods and results

          This prospective, multicentre, single-arm study was conducted at six European sites and enrolled patients with symptomatic paroxysmal atrial fibrillation. The primary effectiveness endpoint was entrance block in treated pulmonary veins (PVs) after adenosine/isoproterenol challenge. The primary safety endpoint was the occurrence of primary adverse events (PAEs) within 7 days. Cerebral magnetic resonance imaging and neurological assessments were performed pre- and post-ablation in a subset of patients. Atrial arrhythmia recurrence was assessed over 12 months via transtelephonic and Holter monitoring. Quality of life was assessed by the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire. Of 85 patients undergoing ablation per study protocol, PV entrance block was achieved in all (one PV required touch-up with a focal catheter). Acute reconnection of ≥1 PVs after adenosine/isoproterenol challenge was observed in 9.3% (30/324) of PVs ablated. Post-ablation, silent cerebral lesions were detected in 9.7% (3/31) of patients assessed, all of which was resolved at 1-month follow-up. One patient experienced a PAE (retroperitoneal bleed). Freedom from documented symptomatic and all arrhythmia was 72.2% and 65.8% at 12 months. Four patients (4.7%) underwent repeat ablation. Significant improvements in all AFEQT subscale scores were seen at 6 and 12 months.

          Conclusion

          PVI with the novel RFB demonstrated favourable safety and effectiveness, with low repeat ablation rate and clinically meaningful improvement in quality of life.

          ClinicalTrials.gov Registration Number

          NCT03437733.

          Graphical Abstract

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial

          Advanced generation ablation technologies have been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial fibrillation (AF) ablation.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Pulsed Field Ablation for Pulmonary Vein Isolation in Atrial Fibrillation

            Catheter ablation of atrial fibrillation using thermal energies such as radiofrequency or cryothermy is associated with indiscriminate tissue destruction. During pulsed field ablation (PFA), subsecond electric fields create microscopic pores in cell membranes-a process called electroporation. Among cell types, cardiomyocytes have among the lowest thresholds to these fields, potentially permitting preferential myocardial ablation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found
              Is Open Access

              Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial.

              Catheter ablation is important for treatment of paroxysmal atrial fibrillation (PAF). Limited animal and human studies suggest a correlation between electrode-tissue contact and radiofrequency lesion generation.
                Bookmark

                Author and article information

                Journal
                Europace
                Europace
                europace
                Europace
                Oxford University Press
                1099-5129
                1532-2092
                June 2021
                15 January 2021
                15 January 2021
                : 23
                : 6
                : 851-860
                Affiliations
                [1 ] Department of Cardiology, St. Bartholomew’s Hospital , W Smithfield, London EC1A 7BE, UK
                [2 ] Monzino Cardiology Center, University of Milan , Via Carlo Parea, 4, 20138 Milano MI, Italy
                [3 ] Department of Cardiology, Ospedale Generale Regionale “F. Miulli” , Strada Prov. 127 Acquaviva—Santeramo Km. 4, 70021 Acquaviva delle Fonti BA, Italy
                [4 ] Department of Cardiology, Na Homolce Hospital , Roentgenova 37, 150 00 Praha 5, Czechia
                [5 ] Heart Rhythm Management Center, Universitair Ziekenhuis Brussels , Avenue du Laerbeek 101, 1090 Jette, Belgium
                [6 ] Biosense Webster, Inc , 29b Technology Dr, Irvine, CA, USA
                [7 ] Liverpool Heart and Chest Hospital, Thomas Dr , Liverpool L14 3PE, UK
                [8 ] Department of Electrophysiology, Division of Cardiology, Icahn School of Medicine at Mount Sinai , 1 Gustave L. Levy Pl, New York, NY, USA
                Author notes
                Corresponding author. Tel: +44 2039832400. E-mail address: richard.schilling@ 123456nhs.net
                Author information
                https://orcid.org/0000-0002-0621-8241
                https://orcid.org/0000-0002-9347-8884
                https://orcid.org/0000-0002-3490-090X
                Article
                euaa382
                10.1093/europace/euaa382
                8186540
                33450010
                77753857-6eb2-46d8-8a3e-9fcae230cb1e
                © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

                History
                : 14 August 2020
                : 09 December 2020
                : 28 November 2020
                Page count
                Pages: 10
                Funding
                Funded by: Biosense Webster, Inc;
                Categories
                Clinical Research
                Ablation for Atrial Fibrillation
                AcademicSubjects/MED00200

                Cardiovascular Medicine
                atrial fibrillation,radiofrequency ablation,pulmonary vein isolation,electrophysiological mapping,radiofrequency balloon catheter,quality of life

                Comments

                Comment on this article